3 Year Absolute Returns
26.47% ↑
NAV (₹) on 21 Oct 2026
24.96
1 Day NAV Change
-0.02%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment of ₹100. The ... Read more
AUM
₹ 3,750.04 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 66.30% |
| Hospitals & Medical Services | 16.49% |
| Foreign Securities | 8.21% |
| Treps/Reverse Repo | 6.81% |
| International Mutual Fund Units | 1.10% |
| Finance - Non Life Insurance | 1.02% |
| Medical Equipment & Accessories | 0.14% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| IPCA Laboratories Limited | 8.13% | ₹ 305.01 | Pharmaceuticals |
| Sun Pharmaceutical Industries Limited | 7.44% | ₹ 278.96 | Pharmaceuticals |
| Cipla Limited | 7.18% | ₹ 269.39 | Pharmaceuticals |
| TREPS / Reverse Repo Investments | 6.81% | ₹ 255.23 | Others |
| Sai Life Sciences Limited | 6.52% | ₹ 244.33 | Pharmaceuticals |
| Gland Pharma Limited | 6.15% | ₹ 230.58 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.07% | ₹ 227.60 | Hospitals & Medical Services |
| Globus Medical Inc | 5.15% | ₹ 193.24 | Others |
| Alkem Laboratories Limited | 4.75% | ₹ 177.96 | Pharmaceuticals |
| Divi's Laboratories Limited | 4.17% | ₹ 156.30 | Pharmaceuticals |
| Cohance Lifesciences Limited | 3.79% | ₹ 142.21 | Pharmaceuticals |
| Alembic Pharmaceuticals Limited | 3.18% | ₹ 119.07 | Pharmaceuticals |
| Kovai Medical Center And Hospital Limited | 2.83% | ₹ 106.21 | Hospitals & Medical Services |
| Pfizer Limited | 2.72% | ₹ 102.16 | Pharmaceuticals |
| Concord Biotech Limited | 2.70% | ₹ 101.07 | Pharmaceuticals |
| Procter & Gamble Health Limited | 2.36% | ₹ 88.61 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 2.36% | ₹ 88.52 | Hospitals & Medical Services |
| Indoco Remedies Limited | 2.26% | ₹ 84.93 | Pharmaceuticals |
| Intuitive Surgical Inc | 1.95% | ₹ 73.25 | Others |
| Thyrocare Technologies Limited | 1.91% | ₹ 71.64 | Hospitals & Medical Services |
| Manipal Health Enterprises Limited | 1.85% | ₹ 69.42 | Hospitals & Medical Services |
| Unichem Laboratories Limited | 1.64% | ₹ 61.57 | Pharmaceuticals |
| Syngene International Limited | 1.35% | ₹ 50.60 | Pharmaceuticals |
| Nephrocare Health Services Limited | 1.12% | ₹ 41.89 | Hospitals & Medical Services |
| Global X Funds - Global X Genomics & Biotechnology ETF | 1.10% | ₹ 41.44 | Others |
| ICICI Lombard General Insurance Co Limited | 1.02% | ₹ 38.38 | Finance - Non Life Insurance |
| Aarti Drugs Limited | 0.98% | ₹ 36.72 | Pharmaceuticals |
| Abbott Laboratories | 0.80% | ₹ 29.98 | Others |
| Eris Lifesciences Limited | 0.72% | ₹ 26.92 | Pharmaceuticals |
| Jupiter Life Line Hospitals Limited | 0.35% | ₹ 13.10 | Hospitals & Medical Services |
| Grail Inc | 0.31% | ₹ 11.75 | Others |
| Abbott India Limited | 0.26% | ₹ 9.92 | Pharmaceuticals |
| Laxmi Dental Limited | 0.14% | ₹ 5.37 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 5.49% | 0.22% | -5.89% | 8.14% |
| Category returns | 3.14% | -1.22% | 1.10% | 18.59% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.47 | 97.94% | 295.52% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.47 | 97.94% | 295.52% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.47 | 97.94% | 295.52% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.14 | 95.31% | 279.57% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.14 | 95.31% | 279.57% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.14 | 95.31% | 279.57% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.34 | 15.31% | 139.64% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.34 | 15.31% | 139.64% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.34 | 15.31% | 139.64% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.27 | 14.21% | 132.02% | 0.00% | ₹11,493 | 1.79% |
Very High
|
What is the current NAV of DSP Healthcare Fund Regular IDCW?
What is the fund size (AUM) of DSP Healthcare Fund Regular IDCW?
What are the historical returns of DSP Healthcare Fund Regular IDCW?
What is the risk level of DSP Healthcare Fund Regular IDCW?
What is the minimum investment amount for DSP Healthcare Fund Regular IDCW?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article